Search
for
Sort by
Research 481–510 of 1000+
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Skin disorders in elderly subjects
- Innovative Uses for Zinc in Dermatology
- Assessment of Vitamin D Level in Patients of Alopecia Areata
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- A case report on the effective management of canine demodicosis
- Mechanistic study of Erianin in alopecia areata
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Dermatologic manifestations of endocrine disorders
- Diffuse loss of hair with papules
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- Sarcoidosis: Are there differences in your skin of color patients?
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Ophthalmologic Comorbidities in Alopecia Areata
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- POS1171 LIVING WITH LUPUS NEPHRITIS: ELEVATED IMPACT ON PATIENT LIFE
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- 413 DC-HIL+ myeloid-derived suppressor cells are elevated in the peripheral blood and lesional skin of cutaneous lupus patients
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases